Table 5.
Differences in Clinical Characteristics and Laboratory Findings Between Patients Who Survived and Patients Who Died for Patients with Rhabdomyolysis (33 Patients)
| Clinical Characteristic or Laboratory Finding | Patients with Rhabdomyolysis | ||
|---|---|---|---|
| Survived (22) | Died (11) | P-value | |
| Age (years), mean ± SD | 50.09 ± 14.20 | 58.45 ± 12.41 | 0.107 |
| Sex (%) | |||
| Male | 10 (45.5) | 6 (54.5) | 0.622 |
| Female | 12 (54.5) | 5 (45.5) | |
| AKI (35 cases) (%) | 6 (27.3) | 11 (100) | <0.001 |
| Shock during hospitalisation (%) | 5 (22.7) | 6 (54.5) | 0.117 |
| Hyperkalaemia during hospitalisation (32 cases) (%) | 2 (of 20) (10) | 8 (of 10) (80) | <0.001 |
| Initial CPK results (IU/L), median (min–max) | 27,882.5 (1221–284,720) | 39,157 (2746–179,506) | 0.492 |
| Maximum CPK results (IU/L), median (min–max) | 36,245.5 (8616–330,000) | 86,544 (34,449–179,506) | 0.029 |
| Initial AST results (IU/L), median (min–max) | 709 (51–8066) | 200 (33–4083) | 0.456 |
| Maximum AST results (IU/L), median (min–max) | 1141 (538–8066) | 2157 (69–4083) | 0.593 |
| Initial ALT results (IU/L), median (min–max) | 225.5 (30–4080) | 76 (30–1103) | 0.302 |
| Maximum ALT results (IU/L), median (min–max) | 460 (135–4080) | 464 (32–1791) | 0.819 |
| Maximum CK-MB results (IU/L), median (min–max) | 1313.5 (300–2800) | 3018.5 (50–7649) | 0.439 |
| Initial potassium results (mmol/L), mean ± SD | 4.03 ± 0.46 | 4.68 ± 0.85 | 0.045 |
| Maximum potassium results (mmol/L), mean ± SD | 4.25 ± 0.74 | 5.60 ± 0.98 | <0.001 |
| Initial creatinine results (mg/dL), median (min–max) | 0.84 (0.36–3.11) | 1.31 (0.58–3.60) | 0.054 |
| Maximum creatinine results (mg/dL), median (min–max) | 0.84 (0.36–9.96) | 2.46 (1.31–7.70) | 0.001 |
Abbreviations: AKI, acute kidney injury; AST, aspartate aminotransferase; ALT, alanine transaminase; CPK, creatine phosphokinase; CK-MB, creatine kinase-MB.